Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
about
Diagnosis and therapy of non-variceal upper gastrointestinal bleedingBenefits and harms of endoscopic screening for gastric cancerProthrombotic and hemorrhagic effects of aspirin.Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke.Thrombotic events associated to aspirin therapy.Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agentsWithdrawal of antithrombotic agents and its impact on ischemic stroke occurrence.Drug discontinuation effects are part of the pharmacology of a drugPlatelets Proteomic Profiles of Acute Ischemic Stroke Patients.Spontaneous Early Recanalization after Acute Innominate Artery Thromboembolic Occlusion Secondary to Abrupt Aspirin and Statin Discontinuation: A Case Report.Withdrawal of Antithrombotic Agents and the Risk of Stroke.Secondary haemorrhage after rubber band ligation of haemorrhoids in patients taking clopidogrel--a cautionary noteA survey of the peri-operative management of urological patients on clopidogrel.Aspirin allergy desensitization in cerebrovascular disease. A report of two cases, literature review and management guide for the neurointerventionalist.The impact of antiplatelet medication on hand and wrist surgery.Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation.Dental extraction can be performed safely in patients on aspirin therapy: a timely reminderPerioperative ischemic stroke in non-cardiovascular surgery patients.Quality measures for medication continuity in long-term care facilities, using a structured panel process.Commonly asked questions in the management of perioperative stroke.Polyglycolic Acid Felt Sealing Method for Prevention of Bleeding Related to Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents.Peri-procedural use of anticoagulants in radiology: an evidence-based review.The Neurostimulation Appropriateness Consensus Committee (NACC): Recommendations on Bleeding and Coagulation Management in Neurostimulation Devices.Continuation of antithrombotic therapy may be associated with a high incidence of colonic post-polypectomy bleeding.Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities.Paradoxical effect of aspirin.Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection.The concept of 'Semi-clean colon' using the pit pattern classification system has the potential to be acceptable in combination with a <3-year surveillance colonoscopy.Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid: a quantitative study in patients with cardiovascular risk.New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.Aspirin discontinuation syndromes: clinical implications of basic research studies.Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?Delayed transient worsening of neurological deficits after ischaemic stroke.Perioperative Vision Loss after Non-Ocular Surgery.Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death.
P2860
Q26777626-507AC361-9602-4171-A722-15530D65C778Q28079409-1A0C2C8D-60CD-4FC2-9A12-7DACE3800D48Q33349385-54717C11-B50E-4DF3-BCDA-68774EB3736AQ33899911-05A0BCF2-C415-4128-9A0D-59ABB78CE913Q34111104-2E75B57D-A0E6-430E-B2B4-AB1C286C9711Q34873381-827CE84C-DF50-4B84-B9E8-1387A991C0E5Q35194074-D2B36AA5-29E4-4CAF-9B73-5348C063F201Q35430065-5617E0F3-4F59-41C0-8554-A42AF108FD02Q36060003-C6D3FF48-3351-49D3-BD4C-900C5B01CCE3Q36306521-5924E13A-9860-4F21-9EA7-03781B5BE9EFQ36706241-CF6AA2AF-912C-489E-8726-313D4B56CB66Q36777414-2E9A99C4-80DA-4CF5-A14C-9B02DC009D40Q37358726-260CCFA1-23C6-46B4-B263-168D146F8D66Q37676410-64D2F765-8983-4DD6-B3ED-B3F8501A2371Q37707869-047982D6-3B3F-4DE6-8E92-F5425D4F182EQ37718219-DEC79920-0B21-44AE-AA8A-F534FF77F4BCQ37731105-321B8852-7F45-4722-8880-90E466B7CDD8Q37765219-B12B92FA-0B08-4963-973A-8DFE4A26DF1BQ37998512-81B92A72-4F52-48F5-8CC9-D969017CD29CQ38078027-1F458303-776E-4BF7-A051-B944E7AEB655Q38956278-F074A698-7807-452D-BC97-8A4A0FC73729Q39077699-0A4B19F7-363F-40F8-A129-3998B18DA99AQ39161825-E4D8DF8D-85AB-4F5A-8C36-40665B004153Q39220763-51098199-BA00-4BAC-AA3D-A5F2950A0FA2Q40553543-3890F080-7166-472F-B4A6-68B5D124A181Q40627802-202EC586-4C6B-4B76-93FE-049BB6141116Q40952316-6A67B1DE-4044-4A4F-AC71-ADE619CB988BQ41600824-902E1847-743C-41DE-804C-D07ED2AF4B48Q44974747-CAE446E0-5F99-4C1B-A1FB-52E4790D0A79Q45019665-37082D43-7310-4274-BECD-4D7B6A800F98Q45748874-7CE11553-E634-460E-BE21-FB502617FCCEQ46138029-FD7221BF-81D3-4D66-A560-C10FC3D12A6DQ48602799-D7DD2356-588C-4024-97C2-2A4E2C99283FQ50206376-95951355-2BC6-4056-A5AB-2F09DE367C26Q53270577-5134BD36-AA27-47DB-B308-0BA1A9ED740A
P2860
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@en
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@nl
type
label
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@en
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@nl
prefLabel
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@en
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@nl
P1433
P1476
Antiplatelet drug discontinuation is a risk factor for ischemic stroke.
@en
P2093
Igor Sibon
Jean-Marc Orgogozo
P304
P356
10.1212/01.WNL.0000118288.04483.02
P407
P50
P577
2004-04-01T00:00:00Z